Absence of herpes virus entry mediator (HVEM) increases bone mass by attenuating receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis

Endocrinology

Volumn 153, Issue 10, 2012, Pages 4808-4817

  Kim, Woon Ki ^a   Sul, Ok Joo ^a   Choi, Eun Kyung ^a   Lee, Mi Hyun ^a   Jeong, Choon Soo ^a   Kim, Hyun Ju ^b   Kim, Shin Yoon ^b   Suh, Jae Hee ^c   Yu, Rina ^a   Choi, Hye Seon ^a  

^a University of Ulsan   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN TYPE 1; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; BONE MASS; BONE REMODELING; CONTROLLED STUDY; DENTIN; IN VITRO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE DENSITY; BONE RESORPTION; COLLAGEN TYPE I; MICE; MICE, KNOCKOUT; OSTEOCLASTS; PEPTIDE FRAGMENTS; RANK LIGAND; REACTIVE OXYGEN SPECIES; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14;

EID: 84866772634     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1079     Document Type: Article

References (31)

1. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357 (Pubitemid 30649812)
2. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323
3. Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y 1998 The TRAF family of signal transducers mediates NF-kB activation by the TRANCE receptor. J Biol Chem 273:28355-28359 (Pubitemid 28496137)
4. Iotsova V, Caamaño J, Loy J, Yang Y, Lewin A, Bravo R 1997 Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med 3:1285-1289 (Pubitemid 27508833)
5. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901 (Pubitemid 35460788)
6. Yang CR, JH Wang, Hsieh SL, Wang SM, Hsu TL, Lin WW 2004 Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differentiation 11(Suppl):S97-S107 (Pubitemid 39136802)
7. Shin HH, Kim SJ, Lee DS, Choi HS 2005 The soluble glucocorticoidinduced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation induced by receptor activator of NF-κB Ligand (RANKL) in osteoclast cells. Bone 36:832-839
8. Shin HH, Lee EA, Kim SJ, Kwon BS, Choi HS 2006Asignal through 4-1BB ligand inhibits receptor for activation of nuclear factor-κB ligand-induced osteoclastogenesis by increasing interferon-beta production. FEBS Lett 580:1601-1606 (Pubitemid 43290358)
9. Shin HH, Lee JE, Lee EA, Kwon BS, Choi HS 2006 Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J Bone Miner Res 21:1907-1912 (Pubitemid 44851567)
10. Yokoyama M, Ukai T, Ayon Haro ER, Kishimoto T, Yoshinaga Y, Hara Y 2011 Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis. J Periodontal Res 46:464-474
11. Montgomery RI, Warner MS, Lum BJ, Spear PG 1996 Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436 (Pubitemid 26374317)
12. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A 1997 Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcriptionfactors NF-κB and AP-1. J Biol Chem 272:14029-14032 (Pubitemid 27232801)
13. Murphy KM, Nelson CA, Sedý JR 2006 Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 6:671-681 (Pubitemid 44298216)
14. Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L 2000 LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cellmediated allogenic T cell response. J Immunol 164:4105-4110 (Pubitemid 30215066)
15. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT 2001 The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167:2479-2486 (Pubitemid 32768873)
16. Heo SK, Ju SA, Lee SC, Park SM, Choe SY, Kwon B, Kwon BS, Kim BS 2006 LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM. J Leukoc Biol 79:330-338 (Pubitemid 44831165)
17. Kim WK, Park JS, Sul OJ, Seo JH, Choi BK, Park HY, Latour AM, Koller BH, Kwon BS, Jeong CS 2011 Role of TNFR-related 2 mediated immune responses in dextran sulfate sodium-induced inflammatory bowel disease. Mol Cells 31:99-104
18. Lee JE, Shin HH, Lee EA, Phan TV, Choi HS 2007 Stimulation of osteoclastogenesis by enhanced level of MIP-1alpha; in BALB/c mice. Exp Hematol 35:1100-1108
19. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163:434-442 (Pubitemid 29295871)
20. Fuller K, Kirstein B, Chambers TJ 2006 Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147:1979-1985
21. Sheng ZF, Xu K, Ma YL, Liu JH, Dai RC, Zhang YH, Jiang YB, Liao EY 2009 Zoledronate reverses mandibular bone loss in osteoprotegrin-deficient mice. Osteoporos Int 20:151-159
22. 2+ oscillations essential for osteoclastogenesis. J Biol Chem 285:6913-6921
23. Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A 2006 Light, a novel mediator of bone resorption, is elevated in rheumatic arthritis. Arthritis Rheum 54:1451-1462
24. Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H 2005 TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA 102:2874-2879 (Pubitemid 40299884)
25. Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, De Fougerolles AR, Sprague A, Browning JL 2003 A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 171:115-126 (Pubitemid 36745279)
26. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, Takayanagi H 2005 Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202:1261-1269 (Pubitemid 41586956)
27. Ha YJ, Lee JR 2004 Role of TNF receptor-associated factor 3 in the CD40 signaling by production of reactive oxygen species through association with p40phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase. J Immunol 172:231-239 (Pubitemid 38020476)
28. Shen HM, Pervaiz S 2006 TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20:1589-1598 (Pubitemid 44943796)
29. Zorov DB, Juhaszova M, Sollott SJ 2006 Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 1757:509-517
30. Lean JM, Davis JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ 2003 A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915-923 (Pubitemid 38063749)
31. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ 2005 Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146:728-735 (Pubitemid 40129828)